NTC works with biopharmaceutical corporate partners to develop safe and efficacious vectors for all biotechnology applications. NTC’s Gene Self-Assembly (GENSA™) technology uses strictly rational design, single base precision cloning, which is not dependent upon restriction sites.
*Some of the advantages of working with NTC to build vectors include:
1) parsimonious construction, compliance with regulatory guidance when needed
2) improved expression
3) removal of antibiotic resistance genes
4) higher productivity through improved plasmid origin of replication.
*Projects are quoted on an individual basis.
